Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
TTV | Ann: December Quarter 12 Appendix 4C | 13:09 | 0 | 358 | |||
|
|||||||
TTV | Ann: Letter to Shareholders | 29/01/13 | 0 | 383 | |||
|
|||||||
TTV | Ann: Closure of Share Offer | 25/01/13 | 0 | 363 | |||
|
|||||||
TTV | Ann: Revised Prospectus Timetable | 16/01/13 | 0 | 373 | |||
|
|||||||
TTV | Ann: Appendix 3B | 16/01/13 | 0 | 333 | |||
|
|||||||
TTV | Ann: Change of Director's Interest Notice | 16/01/13 | 0 | 228 | |||
|
|||||||
TTV | Ann: Update on Appendix 3B | 24/12/12 | 0 | 205 | |||
|
|||||||
TTV | Ann: Letter to Ineligible Shareholders (Bonus Off | 20/12/12 | 0 | 227 | |||
|
See All Discussions